A Novel Biomarker-Based Decision Support System for Pediatric Appendicitis Diagnosis: A Comparative Study of Ensemble Models Algorithms

ArticleAçık Erişim

Özet

Introduction: Acute appendicitis is the commonest cause of surgical abdominal pain, yet diagnosis in children remains challenging; delays increase the risk of perforation, peritonitis and sepsis. We sought to develop a rapid, inexpensive and interpretable clinical-decision support system (CDSS) that leverages routine blood tests (RBT) to assist early paediatric triage. Materials and Methods: In this retrospective single-centre study (January 2020–December 2024) we analysed 275 emergency-department encounters for abdominal pain (75 histology-confirmed appendicitis, 200 controls). The six-stage pipeline comprised (1) cohort selection; (2) exploratory logistic-regression screening of RBT variables; (3) training of Random Forest, Gradient Boosting and LightGBM ensembles (with/without SMOTE) under 10 × 10 stratified cross-validation; (4) SHAP-based feature interpretation; (5) exhaustive generation of every two- and three-parameter arithmetic biomarker from seven RBT features; and (6) derivation of probability-threshold curves and a three-zone rule tree for the top biomarker. Performance was reported with accuracy (ACC), Matthews correlation coefficient (MCC), AUC-ROC, sensitivity, specificity, F1-Score PPV and NPV. Results: Logistic regression and SHAP confirmed CRP, WBC and neutrophil count as strong positive predictors, whereas MPV and PDW were protective; PLT remained non-informative. All three ensemble classifiers surpassed 97% accuracy, 98% AUC-ROC and 0.93 MCC, with no gain from SMOTE. An extensive formula search, the best two-parameter marker was Neutrophil ÷ PDW (MCC = 0.73, specificity 95%). Its ensemble curve crosses P = 0.5 five times; practical cut-offs of < 0.633 (strongly indicate healthy) and > 0.794 (strongly indicate appendicitis) retain high NPV (∼91%) and PPV (∼86%). Among triple formulas that do not rely on PLT, the leading biomarker was CRP+WBC+Neutrophil (MCC = 0.85, PPV 92%, NPV 95%). The ensemble curve intersects at P = 0.5 at three points; values >27 strongly predict appendicitis, <23 indicates a healthy state, and values 23–27 leave a small uncertain band. A rule-based CDSS built on these two biomarkers correctly classified all controls (specificity 100%), sensitivity 95%, achieved 91% overall accuracy, and offers interpretable, electronic health records (EHRs)-ready cut-offs for paediatric appendicitis triage. Conclusion: Routine haematology-biochemistry data, interpreted through ensemble learning and engineered biomarkers, can deliver fast, transparent and highly accurate support for paediatric appendicitis triage. Given its zero false-positive rate, the proposed CDSS is best suited to in-hospital monitoring, where minimising false negatives is critical. Prospective multi-centre validation is warranted. © 2025 AGBM

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/10083Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1016/j.irbm.2025.100921Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAvci, Veli
dc.contributor.authorHuyut, Mehmet Tahir
dc.contributor.authorVelichko, Andrei
dc.contributor.authorBelyaev, Maksim
dc.date.accessioned2026-10-18T20:25:20.119955654Z
dc.date.available2026-10-18T20:25:20.119955654Z
dc.date.issued2026
dc.description.abstractIntroduction: Acute appendicitis is the commonest cause of surgical abdominal pain, yet diagnosis in children remains challenging; delays increase the risk of perforation, peritonitis and sepsis. We sought to develop a rapid, inexpensive and interpretable clinical-decision support system (CDSS) that leverages routine blood tests (RBT) to assist early paediatric triage. Materials and Methods: In this retrospective single-centre study (January 2020–December 2024) we analysed 275 emergency-department encounters for abdominal pain (75 histology-confirmed appendicitis, 200 controls). The six-stage pipeline comprised (1) cohort selection; (2) exploratory logistic-regression screening of RBT variables; (3) training of Random Forest, Gradient Boosting and LightGBM ensembles (with/without SMOTE) under 10 × 10 stratified cross-validation; (4) SHAP-based feature interpretation; (5) exhaustive generation of every two- and three-parameter arithmetic biomarker from seven RBT features; and (6) derivation of probability-threshold curves and a three-zone rule tree for the top biomarker. Performance was reported with accuracy (ACC), Matthews correlation coefficient (MCC), AUC-ROC, sensitivity, specificity, F1-Score PPV and NPV. Results: Logistic regression and SHAP confirmed CRP, WBC and neutrophil count as strong positive predictors, whereas MPV and PDW were protective; PLT remained non-informative. All three ensemble classifiers surpassed 97% accuracy, 98% AUC-ROC and 0.93 MCC, with no gain from SMOTE. An extensive formula search, the best two-parameter marker was Neutrophil ÷ PDW (MCC = 0.73, specificity 95%). Its ensemble curve crosses P = 0.5 five times; practical cut-offs of < 0.633 (strongly indicate healthy) and > 0.794 (strongly indicate appendicitis) retain high NPV (∼91%) and PPV (∼86%). Among triple formulas that do not rely on PLT, the leading biomarker was CRP+WBC+Neutrophil (MCC = 0.85, PPV 92%, NPV 95%). The ensemble curve intersects at P = 0.5 at three points; values >27 strongly predict appendicitis, <23 indicates a healthy state, and values 23–27 leave a small uncertain band. A rule-based CDSS built on these two biomarkers correctly classified all controls (specificity 100%), sensitivity 95%, achieved 91% overall accuracy, and offers interpretable, electronic health records (EHRs)-ready cut-offs for paediatric appendicitis triage. Conclusion: Routine haematology-biochemistry data, interpreted through ensemble learning and engineered biomarkers, can deliver fast, transparent and highly accurate support for paediatric appendicitis triage. Given its zero false-positive rate, the proposed CDSS is best suited to in-hospital monitoring, where minimising false negatives is critical. Prospective multi-centre validation is warranted. © 2025 AGBM
dc.description.sponsorshipThis research was supported by the Russian Science Foundation (grant no. 22-11-00055-P , https://rscf.ru/en/project/22-11-00055/ , accessed on 10 June 2025).
dc.identifier.doi10.1016/j.irbm.2025.100921
dc.identifier.eissn1876-0988
dc.identifier.issn1959-0318
dc.identifier.issue1
dc.identifier.scopus2-s2.0-105022838729
dc.identifier.startpage100921
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/10083
dc.identifier.volume47
dc.identifier.wosWOS:001630920100001
dc.language.isoen
dc.publisherElsevier Masson s.r.l.
dc.relation.ispartofIRBM
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAppendicitis
dc.subjectBiomarkers
dc.subjectBoosting and bagging based ensemble models
dc.subjectClinical decision support system (CDDS)
dc.subjectSHAP
dc.subjectSMOTE
dc.subjectbiological marker
dc.subjectC reactive protein
dc.subjectabdominal pain
dc.subjectadolescent
dc.subjectadult
dc.subjectarithmetic
dc.subjectArticle
dc.subjectchild
dc.subjectclinical decision support system
dc.subjectcohort analysis
dc.subjectcomparative study
dc.subjectcorrelation coefficient
dc.subjectcross validation
dc.subjectdecision tree
dc.subjectdiagnostic accuracy
dc.subjectdiagnostic test accuracy study
dc.subjectelectronic health record
dc.subjectemergency ward
dc.subjectensemble learning
dc.subjectfalse negative result
dc.subjectfemale
dc.subjecthistopathology
dc.subjecthuman
dc.subjectinfant
dc.titleA Novel Biomarker-Based Decision Support System for Pediatric Appendicitis Diagnosis: A Comparative Study of Ensemble Models Algorithms
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus0
rdl.citation.wos0
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)